Rosacea and the Skin Microbiome: Why It’s More Connected to Eczema Than You Think
Christine Kang
Rosacea and eczema look and feel different. Rosacea shows up as persistent facial redness, visible blood vessels, and papules centered on the nose and cheeks. Eczema appears as dry, intensely itchy patches in skin folds and on the body. Most people managing one don’t think of the other as relevant to their experience.
But the microbiome research tells a different story. Both conditions involve disruption along the same sebum-microbiome-inflammation-barrier axis. Both are driven by microbial dysbiosis. Both involve barrier compromise that amplifies immune reactivity. And the same foundational approach — barrier repair, microbiome support, anti-inflammatory actives — benefits both. Understanding how rosacea connects to the broader microbiome picture changes how you think about caring for reactive facial skin.
TL;DR
- Rosacea is a chronic inflammatory skin condition of the central face driven by immune dysregulation, barrier dysfunction, and microbial dysbiosis
- Key pro-inflammatory organisms in rosacea: Demodex folliculorum mites, Staphylococcus epidermidis, and Bacillus oleronius
- Unlike atopic dermatitis where S. aureus dominates, rosacea involves multiple bacterial shifts rather than a single pathogen
- Rosacea skin consistently shows higher transepidermal water loss and compromised barrier function — the same structural vulnerability as atopic dermatitis
- The gut-skin axis plays a significant role — gut dysbiosis amplifies rosacea severity through immune and neuroendocrine pathways
- Copper Tripeptide-1 has documented anti-inflammatory properties specifically relevant to rosacea — suppressing pro-inflammatory cytokines through gene expression modulation
- Microbiome-friendly skincare is now an established therapeutic strategy for rosacea alongside conventional antibiotics and anthelmintics
- The Calm & Restore Duo addresses multiple aspects of rosacea’s underlying axis — barrier support, botanical anti-inflammatory activity, and postbiotic microbiome support
In This Article
- What Is Rosacea and Who Does It Affect?
- What Does the Microbiome Have to Do With Rosacea?
- What Role Do Demodex Mites Play?
- How Does Barrier Dysfunction Drive Rosacea?
- The Gut-Skin Axis and Rosacea
- Why Rosacea and Eczema Are More Connected Than They Look
- What Does a Microbiome-Supportive Approach Look Like for Rosacea?
- FAQs About Rosacea and the Skin Microbiome
What Is Rosacea and Who Does It Affect?
Rosacea is a chronic inflammatory skin condition affecting the central face — the nose, cheeks, chin, and forehead. It’s characterized by persistent redness, visible blood vessels, and in many cases papules and pustules that resemble acne. It affects an estimated 16 million Americans, is more common in women, and typically develops in adults between 30 and 60.
Rosacea is driven by immune dysregulation, genetic predisposition, epidermal barrier dysfunction, and microbial dysbiosis — making it more similar to eczema in its underlying mechanisms than its surface appearance suggests.
There are four subtypes of rosacea recognized clinically:
Erythematotelangiectatic rosacea (ETR) — persistent redness and visible blood vessels, flushing. The most common subtype.
Papulopustular rosacea (PPR) — redness with acne-like breakouts. Often mistaken for adult acne.
Phymatous rosacea — skin thickening, particularly on the nose (rhinophyma). Less common, more prevalent in men.
Ocular rosacea — affects the eyes, causing redness, irritation, and sensitivity to light.
Understanding which subtype you have matters for treatment — but the microbiome connection runs through all four.
Learn more: Beyond Eczema: How the Skin Microbiome Connects Atopic Dermatitis, Seborrheic Dermatitis, Acne, and Rosacea
What Does the Microbiome Have to Do With Rosacea?
This is a different microbiome picture from atopic dermatitis — where S. aureus is the dominant pathogen — but the dynamic is similar. In healthy skin, the microbiome is diverse and balanced. In rosacea-prone skin, that balance shifts toward pro-inflammatory organisms that trigger and amplify immune overreaction.
Staphylococcus epidermidis — normally a beneficial commensal that helps protect against more harmful bacteria — appears in elevated, pro-inflammatory concentrations in rosacea. This is one of the more counterintuitive findings in rosacea research: an organism that is protective in balanced amounts becomes problematic when it dominates.
Bacillus oleronius — a bacterium associated with Demodex mites — produces proteins that trigger the immune response characteristic of rosacea. Its presence is closely linked to Demodex density.
The decline in Cutibacterium acnes — while C. acnes dysbiosis drives acne, certain strains of C. acnes are actually protective on facial skin. Their decline in rosacea contributes to the loss of microbial balance.
Learn more: How to Support Your Skin Microbiome for Healthy, Balanced Skin
What Role Do Demodex Mites Play?
Demodex folliculorum are microscopic mites that live in the hair follicles of nearly every adult human — they’re a normal part of the skin’s ecosystem at low densities. In rosacea-prone skin, their density increases significantly. Demodex abundance is higher in intermediate-stage rosacea patients compared to early-stage patients — suggesting that mite density correlates with disease progression rather than just being a passive presence.
The mechanism is indirect. Demodex mites themselves don’t directly cause rosacea. What they do is carry and harbor bacteria — particularly Bacillus oleronius — that trigger immune responses when mite populations grow large enough. As Demodex density increases, the bacterial load they carry amplifies the inflammatory signaling that drives rosacea symptoms.
This is why ivermectin — an antiparasitic medication that reduces Demodex density — has become an effective treatment for papulopustular rosacea. Reducing the mite population reduces the bacterial load they carry, which reduces the inflammatory trigger.
For skincare, this means that antimicrobial ingredients with activity against the bacterial organisms associated with Demodex — and that support the microbial balance that keeps Demodex populations in check — are directly relevant to rosacea management.
How Does Barrier Dysfunction Drive Rosacea?
Barrier dysfunction is central to rosacea — and it’s one of the clearest connections between rosacea and eczema-prone skin. Lesional areas in rosacea patients show higher transepidermal water loss and lower skin conductivity, indicating a compromised skin barrier.
The compromised barrier in rosacea creates the same self-reinforcing cycle as in atopic dermatitis. A permeable barrier allows more environmental triggers, irritants, and microbial products to reach the immune system. This amplifies immune overreaction — producing more redness, more flushing, more inflammation. That inflammation further damages the barrier. Which allows more penetration. The cycle continues.
What this means for skincare: barrier repair isn’t just a comfort measure for rosacea-prone skin. It directly addresses one of the central mechanisms driving the condition. Ceramides, amino acids that support the skin’s natural moisturizing factor, and barrier-supportive botanicals are therapeutic — not just cosmetic.
The challenge for rosacea-prone skin is that many conventional barrier repair products — rich creams, heavy occlusives — can be too stimulating for reactive facial skin. A lightweight formula that supports barrier function without triggering the neurovascular reactivity that drives flushing is what rosacea-prone skin needs.
Learn more: Steroid-Free Eczema Treatment: What It Means, What the Research Shows
The Gut-Skin Axis and Rosacea
The gut-skin axis — the relationship between gut microbiome health and skin inflammation — is particularly well-established for rosacea. Recent evidence implicates both the gut and skin microbiomes through direct immune interactions and the gut-skin axis in driving cutaneous inflammation and disease severity in rosacea.
People with rosacea have significantly higher rates of gastrointestinal conditions including small intestinal bacterial overgrowth (SIBO), H. pylori infection, and inflammatory bowel disease than the general population. Treatment of these conditions often improves rosacea symptoms — providing direct evidence that gut dysbiosis contributes to skin inflammation through systemic immune pathways.
Practically speaking, this means that managing rosacea effectively involves more than what you put on your skin. Diet, gut microbiome health, and stress management — all of which affect gut microbial balance — directly influence rosacea severity. Korean medicine’s emphasis on internal balance as the foundation of skin health is particularly relevant here. The gut-skin connection that modern research has identified through the lens of microbiome science is the same connection Korean medicine has been addressing through diet and internal botanical remedies for centuries.
Learn more: Prebiotics, Probiotics and Postbiotics in Skincare
Why Rosacea and Eczema Are More Connected Than They Look
The surface presentation of rosacea and atopic dermatitis is genuinely different. But the underlying axis is shared — and understanding this connection has practical implications for people managing both conditions, or for those whose rosacea-prone skin has characteristics of eczema-prone skin (reactivity, barrier compromise, sensitivity to environmental triggers).
Both conditions involve:
- Microbial dysbiosis as a central driver
- Barrier dysfunction that amplifies immune reactivity
- Pro-inflammatory cytokine overproduction — specifically TNF-α and IL-6
- Gut-skin axis involvement
- Stress as a documented trigger through neuroimmune pathways
- Sensitivity to fragrance, sulfates, and harsh actives
The key differences:
- The specific organisms driving dysbiosis (S. aureus in atopic dermatitis vs Demodex-associated bacteria in rosacea)
- The dominant inflammatory pathway (Th2 in atopic dermatitis vs innate immune/neurovascular in rosacea)
- The location (body and face in atopic dermatitis vs central face in rosacea)
- The texture requirements (richer formulas for atopic dermatitis vs lighter formulas for rosacea-prone facial skin)
A microbiome-supportive, barrier-first approach addresses the shared drivers. The formula adjustments — particularly texture — address the differences.
Learn more: Atopic Dermatitis vs Seborrheic Dermatitis: Same Symptoms, Very Different Causes
What Does a Microbiome-Supportive Approach Look Like for Rosacea?
Therapeutic strategies for rosacea now aim to restore microbial balance using narrow-spectrum antibiotics, anthelmintics, topical and oral probiotics, and microbiome-friendly skincare to reduce inflammation, reinforce skin barrier function, and improve clinical outcomes. Microbiome-friendly skincare is now established as part of the therapeutic toolkit — not just a complement to medical treatment.
For daily skincare, the principles are:
Lightweight barrier support — ceramides and amino acids that support barrier function without the heavy texture that can trigger flushing or congestion in rosacea-prone facial skin. The NMF amino acids in the R+R Barrier Recovery Mist — Tryptophan, Threonine, Arginine, Alanine — support barrier hydration at a fundamental level in a mist format that absorbs quickly without occlusion.
Targeted botanical anti-inflammatory activity — the Bi-Om Complex™ in both Treats Lab formulas contains botanicals with documented anti-inflammatory activity through NF-κB and cytokine suppression pathways relevant to rosacea. Coptis Japonica and Scutellaria Baicalensis specifically suppress TNF-α and IL-6 — two of the primary cytokines elevated in rosacea lesional skin.
Postbiotic support — Lactobacillus Ferment in the R+R Barrier Recovery Mist supports microbial balance through the beneficial metabolites of fermentation. Probiotic and postbiotic supplementation shows promise as an adjunctive strategy in rosacea by modulating the microbiome, improving barrier integrity, and reducing inflammation.
Copper Tripeptide-1 — the AI Amino-Peptide Complex™ in the ABC Microbiome Calming Lotion includes Copper Tripeptide-1, which has documented anti-inflammatory gene modulation specifically relevant to rosacea. GHK-Cu suppresses pro-inflammatory cytokine signaling networks and resets inflammatory gene expression toward healthier profiles — directly relevant to the chronic low-grade inflammation that drives rosacea progression. NEOVA’s copper peptide products hold a National Rosacea Society Seal of Acceptance for use on sensitive and inflamed skin — an independent validation of GHK-Cu’s relevance to rosacea-prone skin.
Hedera Helix extract — in the R+R Mist, Hedera Helix contributes anti-inflammatory activity through IL-6 inhibition and antifungal properties through its saponin content — both relevant to the microbial dynamics of rosacea.
Fragrance-free, sulfate-free formulas — non-negotiable for rosacea-prone skin. Fragrance is the most common contact trigger for rosacea flushing. Sulfates disrupt both barrier and microbiome.
FAQs About Rosacea and the Skin Microbiome
→ What causes rosacea?
Rosacea is driven by the interaction of genetic predisposition, immune dysregulation, barrier dysfunction, and microbial dysbiosis. Key pro-inflammatory organisms include Demodex folliculorum mites, Staphylococcus epidermidis in elevated concentrations, and Bacillus oleronius — a bacterium carried by Demodex that triggers immune responses. The neurovascular component — flushing, persistent redness, visible blood vessels — reflects dysregulation in how the skin's vascular and nervous systems respond to these microbial and immune triggers. Common external triggers include heat, sun exposure, spicy foods, alcohol, exercise, and fragranced or harsh skincare products.
→ Is rosacea related to gut health?
Yes — the gut-skin axis connection is well-established for rosacea. People with rosacea have significantly higher rates of gastrointestinal conditions including SIBO, H. pylori infection, and inflammatory bowel disease. Recent evidence implicates both the gut and skin microbiomes in driving cutaneous inflammation and disease severity in rosacea. Treatment of underlying gut conditions often improves rosacea symptoms. Supporting gut microbiome health through diet — particularly fermented foods, reduced sugar and alcohol, and anti-inflammatory dietary patterns — can have measurable benefits for rosacea alongside topical management.
→ What is the difference between rosacea and eczema?
Rosacea and atopic dermatitis are distinct conditions with different presentations and primary mechanisms. Rosacea causes persistent facial redness, visible blood vessels, flushing, and papules on the central face. Atopic dermatitis causes dry, intensely itchy patches in skin folds and on the body, driven by S. aureus dysbiosis and Th2 immune overreaction. Both involve barrier dysfunction and microbiome dysbiosis along the same underlying axis — which is why they share management principles — but the specific organisms, inflammatory pathways, and locations differ. For a full comparison of inflammatory skin conditions: Beyond Eczema: How the Skin Microbiome Connects These Conditions.
→ Can skincare make rosacea worse?
Yes — several common skincare ingredients and practices trigger or worsen rosacea. Fragrance is the most common contact trigger for flushing. Sulfates strip the barrier and disrupt the microbiome. Alcohol-based products are drying and barrier-disrupting. High-concentration exfoliating acids can irritate an already reactive barrier. Physical scrubs and harsh cleansing are particularly problematic for rosacea-prone facial skin. Heavy, occlusive creams can trigger congestion and flushing in some rosacea subtypes. Fragrance-free, lightweight, barrier-supportive formulas are the appropriate foundation for rosacea-prone skin.
→ What skincare ingredients are good for rosacea?
Ingredients with documented relevance to rosacea include: Copper Tripeptide-1 (GHK-Cu) — anti-inflammatory gene modulation specifically studied for rosacea, suppressing pro-inflammatory cytokines; botanical anti-inflammatories that inhibit TNF-α and IL-6 including Coptis Japonica and Scutellaria Baicalensis; postbiotics like Lactobacillus Ferment that support microbial balance; ceramides and NMF amino acids for lightweight barrier support; and Hedera Helix for IL-6 inhibition and antifungal support. All of these are in the Calm & Restore Duo. Avoid fragrance, sulfates, alcohol, and harsh actives.
→ Does Demodex cause rosacea?
Demodex folliculorum mites don't directly cause rosacea — they're present on the skin of nearly every adult human. In rosacea-prone skin, Demodex density increases, and the bacteria they carry — particularly Bacillus oleronius — trigger the immune responses that drive rosacea symptoms. Ivermectin, an antiparasitic that reduces Demodex density, is an effective prescription treatment for papulopustular rosacea precisely because reducing mite density reduces the bacterial load driving inflammation. For skincare, ingredients that support the microbial balance that keeps Demodex populations in check are directly relevant.
→ Can you have both rosacea and eczema?
Yes — having both is more common than most people realize. Both conditions involve barrier compromise and immune dysregulation that makes the skin more reactive overall. Managing both simultaneously requires a formula that is fragrance-free and lightweight enough for rosacea-prone facial skin, while also providing the barrier repair and microbiome support that eczema-prone skin needs. The shared axis framework means the same foundational approach — barrier support, microbiome-supportive actives, avoidance of disrupting ingredients — benefits both conditions, with texture being the primary adjustment for rosacea-prone skin.
→ Is copper peptide good for rosacea?
Yes — Copper Tripeptide-1 (GHK-Cu) has documented anti-inflammatory properties specifically relevant to rosacea. It suppresses pro-inflammatory cytokine signaling networks and resets inflammatory gene expression toward healthier profiles — directly addressing the chronic low-grade inflammation that drives rosacea progression. GHK-Cu is well-tolerated by sensitive and reactive skin because it is an endogenous molecule — naturally produced by the body as part of its repair cascade. NEOVA's copper peptide products hold a National Rosacea Society Seal of Acceptance, providing independent validation of GHK-Cu's relevance for rosacea-prone skin. Copper Tripeptide-1 is an active ingredient in the ABC Microbiome Calming Lotion.
Rosacea Isn’t Just a Flushing Problem
The research of the last few years has significantly deepened the understanding of rosacea — from a vascular condition with unclear causes to a microbiome-driven inflammatory condition with a well-characterized axis connecting microbial dysbiosis, barrier dysfunction, and immune overreaction. That reframe matters because it points toward a different and more comprehensive approach to management.
The Calm & Restore Duo was formulated for eczema-prone and sensitive skin — but the same axis it addresses is the one driving rosacea. Barrier support through ceramides and NMF amino acids. Microbiome balance through Lactobacillus Ferment and the Bi-Om Complex™. Anti-inflammatory activity through Copper Tripeptide-1 and botanical actives targeting the specific cytokines elevated in rosacea. In a lightweight formula that doesn’t trigger the flushing that heavier products can cause. A daily foundation that works with the skin’s systems rather than suppressing them.